BLGO insider transaction filings
BIOLARGO, INC. — 31 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-07. Screen BLGO transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | CODE KENNETH REAY — Chief Science Officer, Director | Grant/award (A): 532,567 @ $0.11 | EDGAR |
| 2026-07-02 | 4 | Bray Christina Elaine — Director | Grant/award (A): 165,198 (derivative) | EDGAR |
| 2026-07-02 | 4 | Park Linda — Director | Grant/award (A): 165,198 (derivative) | EDGAR |
| 2026-07-02 | 4 | STROMMEN JACK B. — Director | Grant/award (A): 132,159 (derivative) | EDGAR |
| 2026-07-02 | 4 | Marshall Dennis E — Director | Grant/award (A): 198,238 (derivative) · Grant/award (A): 115,741 (derivative) | EDGAR |
| 2026-07-02 | 4 | CALVERT DENNIS P — President, Director | Grant/award (A): 699,569 @ $0.11 · Grant/award (A): 219,914 @ $0.11 | EDGAR |
| 2026-06-24 | 4 | Marshall Dennis E — Director | Grant/award (A): 40,909 (derivative) | EDGAR |
| 2026-04-02 | 4 | CODE KENNETH REAY — Chief Science Officer, Director | Grant/award (A): 69,444 @ $0.16 | EDGAR |
| 2026-04-01 | 4 | Bray Christina Elaine — Director | Grant/award (A): 115,741 (derivative) | EDGAR |
| 2026-04-01 | 4 | Park Linda — Director | Grant/award (A): 115,741 (derivative) | EDGAR |
| 2026-04-01 | 4 | STROMMEN JACK B. — Director | Grant/award (A): 92,593 (derivative) | EDGAR |
| 2026-04-01 | 4 | Marshall Dennis E — Director | Grant/award (A): 138,889 (derivative) · Grant/award (A): 115,741 (derivative) | EDGAR |
| 2026-02-03 | 4 | DARGAN CHARLES K — Chief Financial Officer | Grant/award (A): 300,000 (derivative) | EDGAR |
| 2026-01-05 | 4 | Bray Christina Elaine — Director | Grant/award (A): 101,736 (derivative) | EDGAR |
| 2026-01-05 | 4 | Park Linda — Director | Grant/award (A): 101,736 (derivative) | EDGAR |
| 2026-01-05 | 4 | STROMMEN JACK B. — Director | Grant/award (A): 81,389 (derivative) | EDGAR |
| 2026-01-05 | 4 | CODE KENNETH REAY — Chief Science Officer, Director | Grant/award (A): 54,803 @ $0.18 | EDGAR |
| 2026-01-05 | 4 | Marshall Dennis E — Director | Grant/award (A): 122,084 (derivative) · Grant/award (A): 101,736 (derivative) | EDGAR |
| 2026-01-05 | 4 | CALVERT DENNIS P — President, Director | Grant/award (A): 130,222 @ $0.18 | EDGAR |
| 2025-11-17 | 4 | CODE KENNETH REAY — Chief Science Officer, Director | Grant/award (A): 313,754 @ $0.16 | EDGAR |
| 2025-11-17 | 4 | CALVERT DENNIS P — President, Director | Grant/award (A): 310,269 @ $0.16 | EDGAR |
| 2025-10-02 | 4 | Bray Christina Elaine — Director | Grant/award (A): 110,294 (derivative) | EDGAR |
| 2025-10-02 | 4 | Park Linda — Director | Grant/award (A): 110,294 (derivative) | EDGAR |
| 2025-10-02 | 4 | STROMMEN JACK B. — Director | Grant/award (A): 88,235 (derivative) | EDGAR |
| 2025-10-02 | 4 | Marshall Dennis E — Director | Grant/award (A): 132,351 (derivative) · Grant/award (A): 110,294 (derivative) | EDGAR |
| 2025-07-16 | 4 | CODE KENNETH REAY — Chief Science Officer, Director | Grant/award (A): 181,253 @ $0.20 | EDGAR |
| 2025-07-16 | 4 | CALVERT DENNIS P — President, Director | Grant/award (A): 169,498 @ $0.20 | EDGAR |
| 2025-07-02 | 4 | Bray Christina Elaine — Director | Grant/award (A): 93,750 (derivative) | EDGAR |
| 2025-07-02 | 4 | Park Linda — Director | Grant/award (A): 93,750 (derivative) | EDGAR |
| 2025-07-02 | 4 | STROMMEN JACK B. — Director | Grant/award (A): 75,000 (derivative) | EDGAR |
| 2025-07-02 | 4 | Marshall Dennis E — Director | Grant/award (A): 19,000 (derivative) · Grant/award (A): 112,501 (derivative) · Grant/award (A): 93,750 (derivative) | EDGAR |
Recent 8-K events — BIOLARGO, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-05-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-25 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-05 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-20 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-25 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.06 — Material Impairments 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-15 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-23 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BLGO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →